Polatuzumab Vedotin, Zanubrutinib, Rituximab and Lenalidomide (Pola-Zr2) Regimen in the Treatment of Unfit or Frail Patients with Diffuse Large B-Cell LymphomaZiyang Shi,Qing Shi,Weili Zhao,Li WangBlood（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
